| Date | Title | Description | |
|---|---|---|---|
| 25 Mar 2025 | On business and financial situation | The Company releases the presentation related to its strategy update because of its 2025 Capital Markets Day | Download |
| 25 Feb 2025 | On P&L | The Company releases the press release related to the full year 2024 financial results | Download |
| 25 Feb 2025 | On P&L | The Company releases the full year 2024 financial results presentation | Download |
| 25 Feb 2025 | About Corporate Governance | The Company informs about the agreements adopted by the Board of Directors | Download |
| 07 Feb 2025 | On P&L | The Company informs on some of the results expected by the market consensus | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 22 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 15 March and 21 March 2024 | Download |
| 15 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 8 March and 14 March 2024 | Download |
| 12 Mar 2024 | On business and financial situation | ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies | Download |
| 08 Mar 2024 | Share buy-back , stabilisation and treasury stock programmes | Share Buyback Program: transactions conducted between 1 March and 7 March 2024 | Download |
| 07 Mar 2024 | On corporate transactions | ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives | Download |
Pages
| Date | Title | Description | |
|---|---|---|---|
| 18 Nov 2015 | Convocatorias y acuerdos de Juntas y Asambleas generales | Download | |
| 22 Oct 2015 | información sobre resultados | Download | |
| 22 Oct 2015 | información sobre resultados (2) | Download | |
| 21 Oct 2015 | Otros sobre Gobierno Corporativo | Download | |
| 16 Oct 2015 | Convocatorias y Acuerdos de Juntas y Asambleas Generales | Download |






